

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

(Alliance News) - Syncona Ltd on Wednesday said that its portfolio company, Beacon Therapeutics, has raised USD170 million in a Series B financing.


Syncona Ltd - London-based life science investor owns a diversified portfolio of companies spanning across clinical stages - Chair & Chief Executive O...


(Sharecast News) - Life science investor Syncona announced the addition of two new oncology companies to its portfolio on Thursday.


(Alliance News) - Syncona Ltd on Thursday offered up a resilient set of annual results, swinging to profit after a challenging year thanks in part to ...


(Alliance News) - Syncona Ltd on Monday said it will provide further funding to a newly formed firm created after one of its portfolio companies acqui...